Screening of soluble chemical compounds for their pharmacological properties utilizing transponders
First Claim
Patent Images
1. A method of screening for a chemical compound with a pharmaceutically useful property comprising the steps of:
- (a) providing a solid phase particle having;
(i) a chemical compound associated with the solid phase particle, such association not involving a covalent bond between the chemical compound and the solid phase particle or its part, and(ii) a tag identifying the chemical compound associated with the solid phase;
(b) adding the solid phase particle to a bioassay liquid medium;
(c) causing the dissolution of at least a part of the chemical compound associated with the solid phase particle;
(d) performing a bioassay on the bioassay liquid medium containing the chemical compound;
(e) identifying a chemical compound with a pharmaceutically useful property comprising the steps of;
(i) identifying the solid phase particle associated with the chemical compound with the pharmaceutically useful property, and(ii) determining the identity of the chemical compound with the pharmaceutically useful property by reading the tag.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides a method to rapidly screen chemical compounds by delivering the compounds to the assay as a coating on transponders, rather than as powder or solution. The transponder'"'"'s function is to store data that identify the compound. The data can be decoded in any moment of the assay, and the identity of the desired compound established.
238 Citations
10 Claims
-
1. A method of screening for a chemical compound with a pharmaceutically useful property comprising the steps of:
-
(a) providing a solid phase particle having; (i) a chemical compound associated with the solid phase particle, such association not involving a covalent bond between the chemical compound and the solid phase particle or its part, and (ii) a tag identifying the chemical compound associated with the solid phase; (b) adding the solid phase particle to a bioassay liquid medium; (c) causing the dissolution of at least a part of the chemical compound associated with the solid phase particle; (d) performing a bioassay on the bioassay liquid medium containing the chemical compound; (e) identifying a chemical compound with a pharmaceutically useful property comprising the steps of; (i) identifying the solid phase particle associated with the chemical compound with the pharmaceutically useful property, and (ii) determining the identity of the chemical compound with the pharmaceutically useful property by reading the tag. - View Dependent Claims (2, 3, 4, 5, 7, 8, 9, 10)
-
-
6. The solid phase particle, comprising:
-
(i) a chemical compound associated with the solid phase particle, such association not involving a covalent bond between the chemical compound and the solid phase particle or its part, and (ii) a transponder, said transponder having a serial number encoded in it, such serial number identifying the chemical compound associated with the solid phase.
-
Specification